Non-pharmacological therapies for postviral syndromes, including Long COVID: a systematic review and meta-analysis protocol
IntroductionPostviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the SARS-CoV-2 virus and subsequent development of COVID-19 has shown to have similar effects with individuals continuing to exhibit symptoms fo...
Saved in:
Published in | BMJ open Vol. 12; no. 4; p. e057885 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
British Medical Journal Publishing Group
11.04.2022
BMJ Publishing Group LTD BMJ Publishing Group |
Series | Protocol |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | IntroductionPostviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the SARS-CoV-2 virus and subsequent development of COVID-19 has shown to have similar effects with individuals continuing to exhibit symptoms for greater than 12 weeks. The sustained presence of symptoms is variably referred to as ‘post COVID-19 syndrome’, ‘post-COVID condition’ or more commonly ‘Long COVID’. Knowledge of the long-term health impacts and treatments for Long COVID are evolving. To minimise overlap with existing work in the field exploring treatments of Long COVID, we have only chosen to focus on non-pharmacological treatments.AimsThis review aims to summarise the effectiveness of non-pharmacological treatments for PVS, including Long COVID. A secondary aim is to summarise the symptoms and health impacts associated with PVS in individuals recruited to treatment studies.Methods and analysisPrimary electronic searches will be performed in bibliographic databases including: Embase, MEDLINE, PyscINFO, CINAHL and MedRxiv from 1 January 2001 to 29 October 2021. At least two independent reviewers will screen each study for inclusion and data will be extracted from all eligible studies onto a data extraction form. The quality of all included studies will be assessed using Cochrane risk of bias tools and the Newcastle-Ottawa grading system. Non-pharmacological treatments for PVS and Long COVID will be narratively summarised and effect estimates will be pooled using random effects meta-analysis where there is sufficient methodological homogeneity. The symptoms and health impacts reported in the included studies on non-pharmacological interventions will be extracted and narratively reported.Ethics and disseminationThis systematic review does not require ethical approval. The findings from this study will be submitted for peer-reviewed publication, shared at conference presentations and disseminated to both clinical and patient groups.PROSPERO registration numberThe review will adhere to this protocol which has also been registered with PROSPERO (CRD42021282074). |
---|---|
AbstractList | IntroductionPostviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the SARS-CoV-2 virus and subsequent development of COVID-19 has shown to have similar effects with individuals continuing to exhibit symptoms for greater than 12 weeks. The sustained presence of symptoms is variably referred to as ‘post COVID-19 syndrome’, ‘post-COVID condition’ or more commonly ‘Long COVID’. Knowledge of the long-term health impacts and treatments for Long COVID are evolving. To minimise overlap with existing work in the field exploring treatments of Long COVID, we have only chosen to focus on non-pharmacological treatments.AimsThis review aims to summarise the effectiveness of non-pharmacological treatments for PVS, including Long COVID. A secondary aim is to summarise the symptoms and health impacts associated with PVS in individuals recruited to treatment studies.Methods and analysisPrimary electronic searches will be performed in bibliographic databases including: Embase, MEDLINE, PyscINFO, CINAHL and MedRxiv from 1 January 2001 to 29 October 2021. At least two independent reviewers will screen each study for inclusion and data will be extracted from all eligible studies onto a data extraction form. The quality of all included studies will be assessed using Cochrane risk of bias tools and the Newcastle-Ottawa grading system. Non-pharmacological treatments for PVS and Long COVID will be narratively summarised and effect estimates will be pooled using random effects meta-analysis where there is sufficient methodological homogeneity. The symptoms and health impacts reported in the included studies on non-pharmacological interventions will be extracted and narratively reported.Ethics and disseminationThis systematic review does not require ethical approval. The findings from this study will be submitted for peer-reviewed publication, shared at conference presentations and disseminated to both clinical and patient groups.PROSPERO registration numberThe review will adhere to this protocol which has also been registered with PROSPERO (CRD42021282074). Introduction Postviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the SARS-CoV-2 virus and subsequent development of COVID-19 has shown to have similar effects with individuals continuing to exhibit symptoms for greater than 12 weeks. The sustained presence of symptoms is variably referred to as ‘post COVID-19 syndrome’, ‘post-COVID condition’ or more commonly ‘Long COVID’. Knowledge of the long-term health impacts and treatments for Long COVID are evolving. To minimise overlap with existing work in the field exploring treatments of Long COVID, we have only chosen to focus on non-pharmacological treatments.Aims This review aims to summarise the effectiveness of non-pharmacological treatments for PVS, including Long COVID. A secondary aim is to summarise the symptoms and health impacts associated with PVS in individuals recruited to treatment studies.Methods and analysis Primary electronic searches will be performed in bibliographic databases including: Embase, MEDLINE, PyscINFO, CINAHL and MedRxiv from 1 January 2001 to 29 October 2021. At least two independent reviewers will screen each study for inclusion and data will be extracted from all eligible studies onto a data extraction form. The quality of all included studies will be assessed using Cochrane risk of bias tools and the Newcastle-Ottawa grading system. Non-pharmacological treatments for PVS and Long COVID will be narratively summarised and effect estimates will be pooled using random effects meta-analysis where there is sufficient methodological homogeneity. The symptoms and health impacts reported in the included studies on non-pharmacological interventions will be extracted and narratively reported.Ethics and dissemination This systematic review does not require ethical approval. The findings from this study will be submitted for peer-reviewed publication, shared at conference presentations and disseminated to both clinical and patient groups.PROSPERO registration number The review will adhere to this protocol which has also been registered with PROSPERO (CRD42021282074). Postviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the SARS-CoV-2 virus and subsequent development of COVID-19 has shown to have similar effects with individuals continuing to exhibit symptoms for greater than 12 weeks. The sustained presence of symptoms is variably referred to as 'post COVID-19 syndrome', 'post-COVID condition' or more commonly 'Long COVID'. Knowledge of the long-term health impacts and treatments for Long COVID are evolving. To minimise overlap with existing work in the field exploring treatments of Long COVID, we have only chosen to focus on non-pharmacological treatments. This review aims to summarise the effectiveness of non-pharmacological treatments for PVS, including Long COVID. A secondary aim is to summarise the symptoms and health impacts associated with PVS in individuals recruited to treatment studies. Primary electronic searches will be performed in bibliographic databases including: Embase, MEDLINE, PyscINFO, CINAHL and MedRxiv from 1 January 2001 to 29 October 2021. At least two independent reviewers will screen each study for inclusion and data will be extracted from all eligible studies onto a data extraction form. The quality of all included studies will be assessed using Cochrane risk of bias tools and the Newcastle-Ottawa grading system. Non-pharmacological treatments for PVS and Long COVID will be narratively summarised and effect estimates will be pooled using random effects meta-analysis where there is sufficient methodological homogeneity. The symptoms and health impacts reported in the included studies on non-pharmacological interventions will be extracted and narratively reported. This systematic review does not require ethical approval. The findings from this study will be submitted for peer-reviewed publication, shared at conference presentations and disseminated to both clinical and patient groups. The review will adhere to this protocol which has also been registered with PROSPERO (CRD42021282074). |
Author | Raindi, Devan Marwaha, Steven Cruz Rivera, Samantha Haroon, Shamil Brown, Kirsty Nirantharakumar, Krishnarajah Khunti, Kamlesh Simms-Williams, Nikita McMullan, Christel Aiyegbusi, Olalekan Lee Hotham, Richard Sivan, Manoj Hughes, Sarah E Calvert, Melanie Heining, Dominic Camaradou, Jenny Chandan, Joht Singh Bashir, Nasir Turner, Grace |
AuthorAffiliation | 12 Institute for Mental Health , University of Birmingham , Birmingham , UK 5 University Hospitals Birmingham NHS Foundation Trust , Birmingham , UK 3 COVID END Evidence Network , UK , UK 7 NIHR Birmingham Biomedical Research Centre , University Hospitals Birmingham NHS Foundation Trust , Birmingham , UK 11 Department of Health Sciences , University of Leicester , Leicester , UK 8 Birmingham Health Partners Centre for Regulatory Science and Innovation , University of Birmingham , Birmingham , UK 10 University of Leeds , Leeds , UK 6 Centre for Patient-Reported Outcomes Research , University of Birmingham , Birmingham , UK 2 Health Data Research UK , Birmingham , UK 13 Centre for Patient Reported Outcomes Research and Institute of Applied Health Research , University of Birmingham , Birmingham , UK 9 National Institute for Health Research (NIHR) Applied Research Centre West Midlands , University of Birmingham , Birmingham , UK 1 Institute of Applied Health Research , University of Birmingham , Bir |
AuthorAffiliation_xml | – name: 7 NIHR Birmingham Biomedical Research Centre , University Hospitals Birmingham NHS Foundation Trust , Birmingham , UK – name: 1 Institute of Applied Health Research , University of Birmingham , Birmingham , UK – name: 6 Centre for Patient-Reported Outcomes Research , University of Birmingham , Birmingham , UK – name: 8 Birmingham Health Partners Centre for Regulatory Science and Innovation , University of Birmingham , Birmingham , UK – name: 10 University of Leeds , Leeds , UK – name: 2 Health Data Research UK , Birmingham , UK – name: 5 University Hospitals Birmingham NHS Foundation Trust , Birmingham , UK – name: 3 COVID END Evidence Network , UK , UK – name: 12 Institute for Mental Health , University of Birmingham , Birmingham , UK – name: 9 National Institute for Health Research (NIHR) Applied Research Centre West Midlands , University of Birmingham , Birmingham , UK – name: 11 Department of Health Sciences , University of Leicester , Leicester , UK – name: 13 Centre for Patient Reported Outcomes Research and Institute of Applied Health Research , University of Birmingham , Birmingham , UK – name: 4 School of Dentistry , University of Birmingham , Birmingham , UK |
Author_xml | – sequence: 1 givenname: Joht Singh orcidid: 0000-0002-9561-5141 surname: Chandan fullname: Chandan, Joht Singh email: j.s.chandan.1@bham.ac.uk organization: Health Data Research UK, Birmingham, UK – sequence: 2 givenname: Kirsty orcidid: 0000-0001-9403-1593 surname: Brown fullname: Brown, Kirsty organization: Institute of Applied Health Research, University of Birmingham, Birmingham, UK – sequence: 3 givenname: Nikita orcidid: 0000-0002-4926-1995 surname: Simms-Williams fullname: Simms-Williams, Nikita organization: Institute of Applied Health Research, University of Birmingham, Birmingham, UK – sequence: 4 givenname: Jenny surname: Camaradou fullname: Camaradou, Jenny organization: COVID END Evidence Network, UK, UK – sequence: 5 givenname: Nasir surname: Bashir fullname: Bashir, Nasir organization: School of Dentistry, University of Birmingham, Birmingham, UK – sequence: 6 givenname: Dominic surname: Heining fullname: Heining, Dominic organization: University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK – sequence: 7 givenname: Olalekan Lee orcidid: 0000-0001-9122-8251 surname: Aiyegbusi fullname: Aiyegbusi, Olalekan Lee organization: National Institute for Health Research (NIHR) Applied Research Centre West Midlands, University of Birmingham, Birmingham, UK – sequence: 8 givenname: Grace orcidid: 0000-0002-9783-9413 surname: Turner fullname: Turner, Grace organization: Centre for Patient-Reported Outcomes Research, University of Birmingham, Birmingham, UK – sequence: 9 givenname: Samantha orcidid: 0000-0002-1566-6804 surname: Cruz Rivera fullname: Cruz Rivera, Samantha organization: Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK – sequence: 10 givenname: Richard surname: Hotham fullname: Hotham, Richard organization: Institute of Applied Health Research, University of Birmingham, Birmingham, UK – sequence: 11 givenname: Krishnarajah surname: Nirantharakumar fullname: Nirantharakumar, Krishnarajah organization: Health Data Research UK, Birmingham, UK – sequence: 12 givenname: Manoj orcidid: 0000-0002-0334-2968 surname: Sivan fullname: Sivan, Manoj organization: University of Leeds, Leeds, UK – sequence: 13 givenname: Kamlesh orcidid: 0000-0003-2343-7099 surname: Khunti fullname: Khunti, Kamlesh organization: Department of Health Sciences, University of Leicester, Leicester, UK – sequence: 14 givenname: Devan surname: Raindi fullname: Raindi, Devan organization: School of Dentistry, University of Birmingham, Birmingham, UK – sequence: 15 givenname: Steven surname: Marwaha fullname: Marwaha, Steven organization: Institute for Mental Health, University of Birmingham, Birmingham, UK – sequence: 16 givenname: Sarah E orcidid: 0000-0001-5656-1198 surname: Hughes fullname: Hughes, Sarah E organization: National Institute for Health Research (NIHR) Applied Research Centre West Midlands, University of Birmingham, Birmingham, UK – sequence: 17 givenname: Christel orcidid: 0000-0002-0878-1513 surname: McMullan fullname: McMullan, Christel organization: Centre for Patient-Reported Outcomes Research, University of Birmingham, Birmingham, UK – sequence: 18 givenname: Melanie orcidid: 0000-0002-1856-837X surname: Calvert fullname: Calvert, Melanie organization: Centre for Patient Reported Outcomes Research and Institute of Applied Health Research, University of Birmingham, Birmingham, UK – sequence: 19 givenname: Shamil orcidid: 0000-0002-0096-1413 surname: Haroon fullname: Haroon, Shamil organization: Institute of Applied Health Research, University of Birmingham, Birmingham, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35410933$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk2P0zAQhiO0iF2W_QVIKBIXDoT1Z-xwQELlq1LFXoCrNXHt1lViBzspqvjzuKQsuxzwwbbGz7wzHr2PizMfvCmKpxi9wpjW122_C4PxFUEEV4gLKfmD4oIgxqoacX52535eXKW0Q3kx3nBOHhXnlDOMGkovip-fg6-GLcQedOjCxmnoynFrIgzOpNKGWA4hjXsXczwd_DqG3qSXpfO6m9bOb8pVyNvi5tvy3esSMpJG08PodBnN3pkfJfh12ZsRKvDQHZJL5RDDGHK1J8VDC10yV6fzsvj64f2XxadqdfNxuXi7qlpOm7EyxFpBkSAWamsBA60FozUXDWNYcipqCaTFLWFUctRKYcBSjKHBxBrSSHpZLGfddYCdGqLrIR5UAKd-B0LcKIi5486oVovGSmN0yxmTINoaa6ElB011DTXJWm9mrWFqe7PWxo95MvdE7794t1WbsFcNQoTwYzMvTgIxfJ9MGlXvkjZdB96EKSlSs4ZLgZDI6PN_0F2YYp7iTBHZNOxI0ZnSMaQUjb1tBiN19Io6eUUdvaJmr-SsZ3f_cZvzxxkZuJ6BnP237v8kfwEues6k |
CitedBy_id | crossref_primary_10_1371_journal_pone_0281884 crossref_primary_10_3238_arztebl_m2022_0409 crossref_primary_10_2196_50230 crossref_primary_10_3389_phrs_2024_1606966 crossref_primary_10_1002_cesm_12001 crossref_primary_10_1016_j_explore_2024_04_004 crossref_primary_10_3390_ijerph20043477 crossref_primary_10_1038_s41591_023_02445_x |
Cites_doi | 10.3389/fmed.2021.653516 10.1046/j.1440-1843.2003.00522.x 10.1136/bmj.g7647 10.1136/bmj.39489.470347.AD 10.1016/S0140-6736(21)00947-8 10.1016/j.bbi.2011.06.016 10.1038/nrn3087 10.3389/fped.2018.00373 10.1377/hlthaff.2021.00619 10.1016/S0140-6736(20)32705-7 10.1016/j.rmed.2020.106197 10.1136/bmj.n693 10.1016/S2215-0366(20)30203-0 10.1111/irv.12566 10.1378/chest.128.4.2247 10.1016/S1473-3099(21)00043-8 10.1016/j.lanepe.2021.100122 10.1177/01410768211032850 10.1136/bmj.i4919 10.1136/bmj.l4898 10.1016/S0140-6736(20)32656-8 10.30773/pi.2018.10.22.3 10.4103/1673-5374.152369 10.1136/bmjpo-2020-000797 10.1378/chest.128.3.1393 10.1016/S0140-6736(21)00446-3 10.1136/bmj.38933.585764.AE 10.1136/bmj.n1648 10.1155/2019/9342792 10.1080/21641846.2020.1778227 10.1086/518615 10.1136/bmj.j4008 10.1186/1471-2334-6-15 10.1016/S0025-6196(11)60670-8 10.1101/2020.10.19.20214494 10.1136/bmj.j3453 10.1016/s0140-6736(21)00947-8 10.4065/84.11.1001 10.1136/bmj.n71 10.1101/2021.06.28.21259452 |
ContentType | Journal Article |
Copyright | Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. 2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. 2022 |
Copyright_xml | – notice: Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. – notice: 2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. 2022 |
DBID | 9YT ACMMV CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7X7 7XB 88E 88G 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR BTHHO CCPQU COVID DWQXO FYUFA GHDGH GNUQQ K9- K9. KB0 M0R M0S M1P M2M NAPCQ PIMPY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM DOA |
DOI | 10.1136/bmjopen-2021-057885 |
DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central BMJ Journals ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Psychology Database Nursing & Allied Health Premium Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest One Psychology ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition BMJ Journals ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 2044-6055 |
EndPage | e057885 |
ExternalDocumentID | oai_doaj_org_article_bc79f8eecb5448a7b61c7c85ac3c6a62 10_1136_bmjopen_2021_057885 35410933 bmjopen |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: National Institute for Health Research grantid: COV-LT-0013 funderid: http://dx.doi.org/10.13039/501100000272 – fundername: Medical Research Council grantid: MC_PC_20050 – fundername: ; grantid: COV-LT-0013 |
GroupedDBID | --- 3V. 4.4 53G 5VS 7RV 7X7 7~R 88E 8FI 8FJ 9YT ABUWG ACGFS ACMMV ADBBV AENEX AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BKNYI BPHCQ BTFSW BTHHO CCPQU DIK DWQXO EBS FYUFA GNUQQ GROUPED_DOAJ GX1 H13 HMCUK HYE HZ~ K9- KQ8 M0R M1P M2M M48 M~E NAPCQ O9- OK1 PGMZT PIMPY PQQKQ PROAC PSQYO PSYQQ RHF RHI RMJ RPM UKHRP CGR CUY CVF ECM EIF NPM AAYXX ADRAZ BVXVI CITATION EJD 7XB 8FK COVID K9. PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-b539t-e2ff73072fa6ffa1a367436579441853768a2b1b243850b87eaf311a912fe2983 |
IEDL.DBID | RPM |
ISSN | 2044-6055 |
IngestDate | Tue Oct 22 15:06:38 EDT 2024 Tue Sep 17 21:26:44 EDT 2024 Sat Aug 17 01:57:39 EDT 2024 Wed Dec 18 16:24:26 EST 2024 Thu Nov 21 21:28:28 EST 2024 Sat Sep 28 08:17:40 EDT 2024 Tue Nov 26 16:40:10 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | COVID-19 INFECTIOUS DISEASES REHABILITATION MEDICINE |
Language | English |
License | This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b539t-e2ff73072fa6ffa1a367436579441853768a2b1b243850b87eaf311a912fe2983 |
Notes | Protocol ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 MC and SH are joint senior authors. JSC and KB are joint first authors. |
ORCID | 0000-0003-2343-7099 0000-0002-9561-5141 0000-0001-9122-8251 0000-0002-1566-6804 0000-0002-0334-2968 0000-0001-9403-1593 0000-0002-4926-1995 0000-0002-9783-9413 0000-0001-5656-1198 0000-0002-0878-1513 0000-0002-0096-1413 0000-0002-1856-837X |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002258/ |
PMID | 35410933 |
PQID | 2649289947 |
PQPubID | 2040975 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_bc79f8eecb5448a7b61c7c85ac3c6a62 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9002258 proquest_miscellaneous_2649587007 proquest_journals_2649289947 crossref_primary_10_1136_bmjopen_2021_057885 pubmed_primary_35410933 bmj_journals_10_1136_bmjopen_2021_057885 |
PublicationCentury | 2000 |
PublicationDate | 2022-04-11 |
PublicationDateYYYYMMDD | 2022-04-11 |
PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-11 day: 11 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London – name: BMA House, Tavistock Square, London, WC1H 9JR |
PublicationSeriesTitle | Protocol |
PublicationTitle | BMJ open |
PublicationTitleAbbrev | BMJ Open |
PublicationTitleAlternate | BMJ Open |
PublicationYear | 2022 |
Publisher | British Medical Journal Publishing Group BMJ Publishing Group LTD BMJ Publishing Group |
Publisher_xml | – name: British Medical Journal Publishing Group – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
References | Sterne, Savović, Page (R46) 2019; 366 Guyatt, Oxman, Vist (R49) 2008; 336 Schultz, Hilliard, Cooper (R23) 2009; 84 Gupta, Cantor, Simon (R4) 2021; 40 Daher, Balfanz, Cornelissen (R5) 2020; 174 Wells, Shea, O’Connell (R45) 2015 Rogers, Chesney, Oliver (R25) 2020; 7 Malik, Asprusten, Pedersen (R30) 2020; 4 Salamanna, Veronesi, Martini (R13) 2021; 8 Vernon, Whistler, Cameron (R35) 2006; 6 Shamseer, Moher, Clarke (R40) 2015; 349 Hsieh, Lee, Cho (R21) 2018; 12 Chan, Zheng, Mok (R24) 2003; 8 Suppl Hui, Wong, Ko (R19) 2005; 128 Ong, Ng, Lee (R20) 2005; 128 Sterne, Hernán, Reeves (R47) 2016; 355 Gorna, MacDermott, Rayner (R16) 2021; 397 Hickie, Davenport, Wakefield (R27) 2006; 333 Lee, Shin, Park (R26) 2019; 16 Shea, Reeves, Wells (R44) 2017; 358 Sudre, Murray, Varsavsky (R6) 2020 Huang, Huang, Wang (R12) 2021; 397 Proal, Marshall (R32) 2018; 6 Bansal, Bradley, Bishop (R31) 2012; 26 Islam, Cotler, Jason (R34) 2020; 8 Haas, Angulo, McLaughlin (R2) 2021; 397 Aiyegbusi, Hughes, Turner (R29) 2021; 114 Staniszewska, Brett, Simera (R50) 2017; 358 Page, McKenzie, Bossuyt (R39) 2021; 372 Norton, Olliaro, Sigfrid (R17) 2021; 21 White (R28) 2007; 196 Crook, Raza, Nowell (R37) 2021; 374 Augustin, Schommers, Stecher (R9) 2021; 6 Blomberg, Mohn, Brokstad (R11) 2021 Holgate, Komaroff, Mangan (R36) 2011; 12 Chen, Guo, Zhang (R22) 2019; 2019 Aucott, Rebman (R15) 2021; 397 Ayoubkhani, Khunti, Nafilyan (R10) 2021; 372 Yamato, Kataoka (R33) 2015; 10 Salamanna (2022051704393713000_12.4.e057885.13) 2021; 8 Aucott (2022051704393713000_12.4.e057885.15) 2021; 397 Gorna (2022051704393713000_12.4.e057885.16) 2021; 397 2022051704393713000_12.4.e057885.21 Proal (2022051704393713000_12.4.e057885.32) 2018; 6 2022051704393713000_12.4.e057885.24 2022051704393713000_12.4.e057885.23 2022051704393713000_12.4.e057885.20 Augustin (2022051704393713000_12.4.e057885.9) 2021; 6 2022051704393713000_12.4.e057885.28 2022051704393713000_12.4.e057885.27 Lee (2022051704393713000_12.4.e057885.26) 2019; 16 Rogers (2022051704393713000_12.4.e057885.25) 2020; 7 Norton (2022051704393713000_12.4.e057885.17) 2021; 21 2022051704393713000_12.4.e057885.5 Malik (2022051704393713000_12.4.e057885.30) 2020; 4 2022051704393713000_12.4.e057885.6 2022051704393713000_12.4.e057885.7 2022051704393713000_12.4.e057885.8 2022051704393713000_12.4.e057885.1 2022051704393713000_12.4.e057885.2 2022051704393713000_12.4.e057885.3 2022051704393713000_12.4.e057885.35 2022051704393713000_12.4.e057885.31 2022051704393713000_12.4.e057885.37 2022051704393713000_12.4.e057885.36 2022051704393713000_12.4.e057885.39 2022051704393713000_12.4.e057885.38 Chen (2022051704393713000_12.4.e057885.22) 2019; 2019 Aiyegbusi (2022051704393713000_12.4.e057885.29) 2021; 114 2022051704393713000_12.4.e057885.44 2022051704393713000_12.4.e057885.43 2022051704393713000_12.4.e057885.46 Gupta (2022051704393713000_12.4.e057885.4) 2021; 40 2022051704393713000_12.4.e057885.45 2022051704393713000_12.4.e057885.40 2022051704393713000_12.4.e057885.42 2022051704393713000_12.4.e057885.41 2022051704393713000_12.4.e057885.48 Yamato (2022051704393713000_12.4.e057885.33) 2015; 10 2022051704393713000_12.4.e057885.47 2022051704393713000_12.4.e057885.49 Islam (2022051704393713000_12.4.e057885.34) 2020; 8 2022051704393713000_12.4.e057885.11 2022051704393713000_12.4.e057885.10 2022051704393713000_12.4.e057885.12 2022051704393713000_12.4.e057885.50 2022051704393713000_12.4.e057885.19 2022051704393713000_12.4.e057885.18 2022051704393713000_12.4.e057885.14 |
References_xml | – volume: 8 year: 2021 ident: R13 article-title: Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data publication-title: Front Med doi: 10.3389/fmed.2021.653516 contributor: fullname: Martini – volume: 8 Suppl start-page: S36 year: 2003 ident: R24 article-title: Sars: prognosis, outcome and sequelae publication-title: Respirology doi: 10.1046/j.1440-1843.2003.00522.x contributor: fullname: Mok – volume: 349 start-page: g7647 year: 2015 ident: R40 article-title: Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation publication-title: BMJ doi: 10.1136/bmj.g7647 contributor: fullname: Clarke – start-page: 1 year: 2021 ident: R11 article-title: Long COVID in a prospective cohort of home-isolated patients publication-title: Nat Med contributor: fullname: Brokstad – volume: 336 start-page: 924 year: 2008 ident: R49 article-title: Grade: an emerging consensus on rating quality of evidence and strength of recommendations publication-title: BMJ doi: 10.1136/bmj.39489.470347.AD contributor: fullname: Vist – volume: 358 year: 2017 ident: R50 article-title: GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research publication-title: BMJ contributor: fullname: Simera – volume: 397 start-page: 1819 year: 2021 ident: R2 article-title: Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data publication-title: Lancet doi: 10.1016/S0140-6736(21)00947-8 contributor: fullname: McLaughlin – volume: 26 start-page: 24 year: 2012 ident: R31 article-title: Chronic fatigue syndrome, the immune system and viral infection publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2011.06.016 contributor: fullname: Bishop – volume: 12 start-page: 539 year: 2011 ident: R36 article-title: Chronic fatigue syndrome: understanding a complex illness publication-title: Nat Rev Neurosci doi: 10.1038/nrn3087 contributor: fullname: Mangan – volume: 6 year: 2018 ident: R32 article-title: Myalgic Encephalomyelitis/Chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity publication-title: Front Pediatr doi: 10.3389/fped.2018.00373 contributor: fullname: Marshall – volume: 40 start-page: 1465 year: 2021 ident: R4 article-title: Vaccinations against COVID-19 may have averted up to 140,000 deaths in the United States publication-title: Health Aff doi: 10.1377/hlthaff.2021.00619 contributor: fullname: Simon – volume: 397 start-page: 455 year: 2021 ident: R16 article-title: Long COVID guidelines need to reflect lived experience publication-title: Lancet doi: 10.1016/S0140-6736(20)32705-7 contributor: fullname: Rayner – volume: 174 year: 2020 ident: R5 article-title: Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae publication-title: Respir Med doi: 10.1016/j.rmed.2020.106197 contributor: fullname: Cornelissen – volume: 372 start-page: n693 year: 2021 ident: R10 article-title: Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study publication-title: BMJ doi: 10.1136/bmj.n693 contributor: fullname: Nafilyan – volume: 7 start-page: 611 year: 2020 ident: R25 article-title: Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(20)30203-0 contributor: fullname: Oliver – start-page: 2 year: 2015 ident: R45 article-title: The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. secondary the Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses publication-title: Ottawa Hosp Res Inst contributor: fullname: O’Connell – volume: 12 start-page: 643 year: 2018 ident: R21 article-title: Recovery of pulmonary functions, exercise capacity, and quality of life after pulmonary rehabilitation in survivors of ARDS due to severe influenza A (H1N1) pneumonitis publication-title: Influenza Other Respir Viruses doi: 10.1111/irv.12566 contributor: fullname: Cho – volume: 128 start-page: 2247 year: 2005 ident: R19 article-title: The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors publication-title: Chest doi: 10.1378/chest.128.4.2247 contributor: fullname: Ko – volume: 21 start-page: 601 year: 2021 ident: R17 article-title: Long COVID: tackling a multifaceted condition requires a multidisciplinary approach publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(21)00043-8 contributor: fullname: Sigfrid – volume: 6 year: 2021 ident: R9 article-title: Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study publication-title: Lancet Reg Health Eur doi: 10.1016/j.lanepe.2021.100122 contributor: fullname: Stecher – volume: 372 year: 2021 ident: R39 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ contributor: fullname: Bossuyt – volume: 114 start-page: 428 year: 2021 ident: R29 article-title: Symptoms, complications and management of long COVID: a review publication-title: J R Soc Med doi: 10.1177/01410768211032850 contributor: fullname: Turner – volume: 355 start-page: i4919 year: 2016 ident: R47 article-title: ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions publication-title: BMJ doi: 10.1136/bmj.i4919 contributor: fullname: Reeves – volume: 366 year: 2019 ident: R46 article-title: Rob 2: a revised tool for assessing risk of bias in randomised trials publication-title: BMJ doi: 10.1136/bmj.l4898 contributor: fullname: Page – volume: 397 start-page: 220 year: 2021 ident: R12 article-title: 6-month consequences of COVID-19 in patients discharged from Hospital: a cohort study publication-title: Lancet doi: 10.1016/S0140-6736(20)32656-8 contributor: fullname: Wang – volume: 16 start-page: 59 year: 2019 ident: R26 article-title: Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle East respiratory syndrome survivors publication-title: Psychiatry Investig doi: 10.30773/pi.2018.10.22.3 contributor: fullname: Park – year: 2020 ident: R6 article-title: Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms 1 collected by the Covid symptoms study APP 2 3 medRxiv preprint publication-title: medRxiv contributor: fullname: Varsavsky – volume: 10 start-page: 203 year: 2015 ident: R33 article-title: Fatigue sensation following peripheral viral infection is triggered by neuroinflammation: who will answer these questions? publication-title: Neural Regen Res doi: 10.4103/1673-5374.152369 contributor: fullname: Kataoka – volume: 4 year: 2020 ident: R30 article-title: Cognitive–behavioural therapy combined with music therapy for chronic fatigue following Epstein-Barr virus infection in adolescents: a randomised controlled trial publication-title: BMJ Paediatr Open doi: 10.1136/bmjpo-2020-000797 contributor: fullname: Pedersen – volume: 128 start-page: 1393 year: 2005 ident: R20 article-title: 1-Year pulmonary function and health status in survivors of severe acute respiratory syndrome publication-title: Chest doi: 10.1378/chest.128.3.1393 contributor: fullname: Lee – volume: 397 start-page: 967 year: 2021 ident: R15 article-title: Long-haul COVID: heed the lessons from other infection-triggered illnesses publication-title: Lancet doi: 10.1016/S0140-6736(21)00446-3 contributor: fullname: Rebman – volume: 333 start-page: 575 year: 2006 ident: R27 article-title: Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study publication-title: BMJ doi: 10.1136/bmj.38933.585764.AE contributor: fullname: Wakefield – volume: 374 year: 2021 ident: R37 article-title: Long covid-mechanisms, risk factors, and management publication-title: BMJ doi: 10.1136/bmj.n1648 contributor: fullname: Nowell – volume: 2019 start-page: 1 year: 2019 ident: R22 article-title: Long-Term prognosis of suspected myocarditis and cardiomyopathy associated with viral infection of the myocardial tissue: a meta-analysis of cohort studies publication-title: Cardiovasc Ther doi: 10.1155/2019/9342792 contributor: fullname: Zhang – volume: 8 start-page: 61 year: 2020 ident: R34 article-title: Post-Viral fatigue and COVID-19: lessons from past epidemics publication-title: Fatigue: Biomedicine, Health Behav doi: 10.1080/21641846.2020.1778227 contributor: fullname: Jason – volume: 196 start-page: 4 year: 2007 ident: R28 article-title: What causes prolonged fatigue after infectious mononucleosis: and does it tell us anything about chronic fatigue syndrome? publication-title: J Infect Dis doi: 10.1086/518615 contributor: fullname: White – volume: 358 year: 2017 ident: R44 article-title: AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both publication-title: BMJ doi: 10.1136/bmj.j4008 contributor: fullname: Wells – volume: 6 year: 2006 ident: R35 article-title: Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus publication-title: BMC Infect Dis doi: 10.1186/1471-2334-6-15 contributor: fullname: Cameron – volume: 84 start-page: 1001 year: 2009 ident: R23 article-title: Diagnosis and treatment of viral myocarditis publication-title: Mayo Clin Proc doi: 10.1016/S0025-6196(11)60670-8 contributor: fullname: Cooper – ident: 2022051704393713000_12.4.e057885.6 doi: 10.1101/2020.10.19.20214494 – ident: 2022051704393713000_12.4.e057885.5 doi: 10.1016/j.rmed.2020.106197 – ident: 2022051704393713000_12.4.e057885.41 – volume: 2019 start-page: 1 year: 2019 ident: 2022051704393713000_12.4.e057885.22 article-title: Long-Term prognosis of suspected myocarditis and cardiomyopathy associated with viral infection of the myocardial tissue: a meta-analysis of cohort studies publication-title: Cardiovasc Ther contributor: fullname: Chen – ident: 2022051704393713000_12.4.e057885.3 – ident: 2022051704393713000_12.4.e057885.10 doi: 10.1136/bmj.n693 – ident: 2022051704393713000_12.4.e057885.45 – ident: 2022051704393713000_12.4.e057885.12 doi: 10.1016/S0140-6736(20)32656-8 – ident: 2022051704393713000_12.4.e057885.50 doi: 10.1136/bmj.j3453 – volume: 8 year: 2021 ident: 2022051704393713000_12.4.e057885.13 article-title: Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data publication-title: Front Med doi: 10.3389/fmed.2021.653516 contributor: fullname: Salamanna – ident: 2022051704393713000_12.4.e057885.19 doi: 10.1378/chest.128.4.2247 – ident: 2022051704393713000_12.4.e057885.47 doi: 10.1136/bmj.i4919 – ident: 2022051704393713000_12.4.e057885.11 – ident: 2022051704393713000_12.4.e057885.35 doi: 10.1186/1471-2334-6-15 – volume: 21 start-page: 601 year: 2021 ident: 2022051704393713000_12.4.e057885.17 article-title: Long COVID: tackling a multifaceted condition requires a multidisciplinary approach publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(21)00043-8 contributor: fullname: Norton – ident: 2022051704393713000_12.4.e057885.28 doi: 10.1086/518615 – ident: 2022051704393713000_12.4.e057885.42 – volume: 397 start-page: 967 year: 2021 ident: 2022051704393713000_12.4.e057885.15 article-title: Long-haul COVID: heed the lessons from other infection-triggered illnesses publication-title: Lancet doi: 10.1016/S0140-6736(21)00446-3 contributor: fullname: Aucott – ident: 2022051704393713000_12.4.e057885.40 doi: 10.1136/bmj.g7647 – ident: 2022051704393713000_12.4.e057885.2 doi: 10.1016/s0140-6736(21)00947-8 – ident: 2022051704393713000_12.4.e057885.36 doi: 10.1038/nrn3087 – volume: 6 year: 2018 ident: 2022051704393713000_12.4.e057885.32 article-title: Myalgic Encephalomyelitis/Chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity publication-title: Front Pediatr doi: 10.3389/fped.2018.00373 contributor: fullname: Proal – volume: 10 start-page: 203 year: 2015 ident: 2022051704393713000_12.4.e057885.33 article-title: Fatigue sensation following peripheral viral infection is triggered by neuroinflammation: who will answer these questions? publication-title: Neural Regen Res doi: 10.4103/1673-5374.152369 contributor: fullname: Yamato – volume: 16 start-page: 59 year: 2019 ident: 2022051704393713000_12.4.e057885.26 article-title: Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle East respiratory syndrome survivors publication-title: Psychiatry Investig doi: 10.30773/pi.2018.10.22.3 contributor: fullname: Lee – volume: 6 year: 2021 ident: 2022051704393713000_12.4.e057885.9 article-title: Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study publication-title: Lancet Reg Health Eur contributor: fullname: Augustin – ident: 2022051704393713000_12.4.e057885.23 doi: 10.4065/84.11.1001 – volume: 114 start-page: 428 year: 2021 ident: 2022051704393713000_12.4.e057885.29 article-title: Symptoms, complications and management of long COVID: a review publication-title: J R Soc Med doi: 10.1177/01410768211032850 contributor: fullname: Aiyegbusi – ident: 2022051704393713000_12.4.e057885.24 doi: 10.1046/j.1440-1843.2003.00522.x – ident: 2022051704393713000_12.4.e057885.27 doi: 10.1136/bmj.38933.585764.AE – volume: 8 start-page: 61 year: 2020 ident: 2022051704393713000_12.4.e057885.34 article-title: Post-Viral fatigue and COVID-19: lessons from past epidemics publication-title: Fatigue: Biomedicine, Health Behav contributor: fullname: Islam – volume: 40 start-page: 1465 year: 2021 ident: 2022051704393713000_12.4.e057885.4 article-title: Vaccinations against COVID-19 may have averted up to 140,000 deaths in the United States publication-title: Health Aff doi: 10.1377/hlthaff.2021.00619 contributor: fullname: Gupta – ident: 2022051704393713000_12.4.e057885.43 – volume: 7 start-page: 611 year: 2020 ident: 2022051704393713000_12.4.e057885.25 article-title: Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(20)30203-0 contributor: fullname: Rogers – ident: 2022051704393713000_12.4.e057885.18 – ident: 2022051704393713000_12.4.e057885.21 doi: 10.1111/irv.12566 – ident: 2022051704393713000_12.4.e057885.49 doi: 10.1136/bmj.39489.470347.AD – ident: 2022051704393713000_12.4.e057885.14 – ident: 2022051704393713000_12.4.e057885.39 doi: 10.1136/bmj.n71 – ident: 2022051704393713000_12.4.e057885.46 doi: 10.1136/bmj.l4898 – ident: 2022051704393713000_12.4.e057885.20 doi: 10.1378/chest.128.3.1393 – ident: 2022051704393713000_12.4.e057885.8 – volume: 4 year: 2020 ident: 2022051704393713000_12.4.e057885.30 article-title: Cognitive–behavioural therapy combined with music therapy for chronic fatigue following Epstein-Barr virus infection in adolescents: a randomised controlled trial publication-title: BMJ Paediatr Open contributor: fullname: Malik – ident: 2022051704393713000_12.4.e057885.37 doi: 10.1136/bmj.n1648 – ident: 2022051704393713000_12.4.e057885.48 – ident: 2022051704393713000_12.4.e057885.1 – volume: 397 start-page: 455 year: 2021 ident: 2022051704393713000_12.4.e057885.16 article-title: Long COVID guidelines need to reflect lived experience publication-title: Lancet doi: 10.1016/S0140-6736(20)32705-7 contributor: fullname: Gorna – ident: 2022051704393713000_12.4.e057885.38 – ident: 2022051704393713000_12.4.e057885.31 doi: 10.1016/j.bbi.2011.06.016 – ident: 2022051704393713000_12.4.e057885.7 doi: 10.1101/2021.06.28.21259452 – ident: 2022051704393713000_12.4.e057885.44 doi: 10.1136/bmj.j4008 |
SSID | ssj0000459552 |
Score | 2.3951402 |
Snippet | IntroductionPostviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the... Postviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the SARS-CoV-2... INTRODUCTIONPostviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the... Introduction Postviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to... |
SourceID | doaj pubmedcentral proquest crossref pubmed bmj |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e057885 |
SubjectTerms | Bias Chronic fatigue syndrome Coronaviruses COVID-19 COVID-19 - complications COVID-19 - therapy Epstein-Barr virus Humans INFECTIOUS DISEASES Long COVID Meta-analysis Meta-Analysis as Topic Post-Acute COVID-19 Syndrome Public Health REHABILITATION MEDICINE Research Design SARS-CoV-2 Syndrome Systematic review Systematic Reviews as Topic Viral infections |
SummonAdditionalLinks | – databaseName: BMJ Open Access Journals dbid: 9YT link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3faxQxEA61QimIaNV6WiWCDz50e7dJJpv4ptVSxdaXVurTkuQSrbS7R2_vyX_emf1x54mIL7uwGbIhM5N8k2S-MPbSKxNMApXFqU2ZKiY2c3oaMwfJgpiCmEwpUfjkVB-fq48XcLHB8iEXxl__oGujDvDdZTQQR1PVjHMxVuOI4MIYOKCV6VvsNoAEuq3Bfj1bLqsgQrHQ3rMjJkplCNah5xrKpR5qR9MQGES3lW2zLQmKSJWIOBAF1iaolsf_b-DzzzOUv01KR_fY3R5N8jed-u-zjVjtsK2Tfr98h93pVuV4l2z0gP08ratstmKrJg3xLgULI2aOAJbP6nlDB3-v-EBmMN_nl1W4WtAsxz_V-Dj8_OXDu9fc8RUPNO9yYLirpvw6Ni5zPdsJJyaIGv_2kJ0fvT87PM766xcyD9I2WRQpof8XIjmdksudpIQFDejBxHiDI5NxwudeKGlg4k0RXZJ57mwuUhTWyEdss6qr-Jhx9HSnpACvUlA6BJ98IUEnBckkxKAj9gp7vuzdZ162kYnUZa-vkvRVdvoasf1BPeWsI-T4t_hbUuFSlNi02w_1zbeyd87Sh8ImE2PwgNGqK7zOQxEMuCCDdlqM2N5gAKs2IpK0FK2qYsReLIvROWnHxVWxXnQygCPiBGV2O3tZtmSwuhEr1ixpranrJdXl95YA3BLyAvPk_3vtKdsWlLdBJJX5HttsbhbxGaKpxj9v_ecX550aYA priority: 102 providerName: BMJ Publishing Group Ltd – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV29b9UwELegA2JBfBNakJEYGBo1sX2OzQaFqiBaFoq6RbZjq0Vt8sTLm_rPc5fkfSEEC0sG-yRffB--k32_Y-y1VyaYBCqPjU25qgqbO93E3EGyIBoQRUOFwien-vhMfT6H841WX_QmbIQHHjfuwIfKJhNj8ICZhKu8LkMVDLggg3aT9y3ERjI1-GAFFkBMMEOl1Af--gf1o0KtEJg_o55S9-TbOLp1IA24_X8KNn9_M7lxCB3dZ_em6JG_G7l-wG7F9iG7czLdjz9iN6ddm8_WaNQkAT6WWGFGzDFA5bNu3tPD3iu-BCuY7_PLNlwt6BTjXzr8HH79_unDW-74GueZjzUu3LUNv469y92EZsIJ6aHD1R6zs6OP3w6P86m9Qu5B2j6PIiW070okp1NypZNUkKABLZQQbdDzGCd86YWSBgpvquiSLEtnS5GisEY-YTtt18ZnjKMlOyUFeJWC0iH45CsJOilIJmGMmbE3uNP1ZB7zesg8pK4nodQklHoUSsb2l-KoZyPgxt_J35PIVqSElj0MoA7Vkw7V_9KhjO0tBb7mESNFS9moqjL2ajWNxkc3Kq6N3WKkAfR4BdI8HfVjxYkERVBdMmPVluZssbo9015eDADfliIrMM__x7_tsruCKjYInrLcYzv9z0V8gXFU718OJvMLzFIeAA priority: 102 providerName: Directory of Open Access Journals – databaseName: Coronavirus Research Database dbid: COVID link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZoKyEuvCmBgozEgUPdbvxKzAVBoSqIlgtFvUW2Y0OhTZZu9gJ_npnE2WUr1AOXHJyRYucbj2dszzeEPHey9GVUkoXaRCaLiWFW14FZFY3iteKTGhOFD4_0wbH8cKJO0obbLF2rHG1ib6jr1uMe-S4s3AaDA1m8mv5kWDUKT1dTCY01siHAdQAN39j79OX928UuCzgsRime6IZyoXfd-XesSwXawSGOBn3FKspr0LqyMPX8_f9yOi_fnfxrMdq_RapxGMMdlB87887t-F-XGB7_f5y3yc3kp9LXg2LdIddCc5dcP0wn8ffI76O2YdMl7zViTYdkLoi9KbjCdNrOOrxCfEZHWoTZNj1t_Nkc10v6sYVH_x9fUkuXjNJ0yKahtqnpeegss4k3hSKnRAtfu0-O99993jtgqZADc0qYjgUeI1iSgkerY7S5FZj6oBXYAuTOARtXWu5yxyWgOHFlEWwUeW5NzmPgphQPyHrTNuEhoWAzrBRcORm91N676AqhdJQqlhG82Yy8ACyrNBFnVR_jCF0l2CuEvRpgz8j2CHg1Hag9rhZ_g0qxEEVe7r6hvfhapWleOV-YWIbgnYK41xZO577wpbJeeG01z8jWiPqyj0vIM_Js8RqmOZ7d2Ca080FGgW2dgMzmoIGLngglkRRMZKRY0c2Vrq6-aU6_9VTiBn04VT66uluPyQ2OWR9IcZlvkfXuYh6egC_Wuadpwv0Bn2U4vQ priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Ni9QwFA_rCuJF_La6SgQPHjba5quJIKKryyrOenFkbyVJE12ZbceZDij-87606Ywjq-Clhya04X3k_R7J-z2EHlmunAqCE1_rQHiZa2Jk7YkRQQtaC5rXsVB4ciyPpvzdiTjZQWNX1CTA5bmpXewnNV3Mnnz_9uMFOPzz1JHkqT37GodA4RRSYzBBJS6gixRCY7zjNUl4v9-audCi78JDc84JQHmRmIj-8h2IOPB2K2b11P7n4dE_r1X-FqcOr6IrCWDil4NFXEM7vrmOLk3SEfoN9PO4bch8Q1gdlYSHKixImjFgWDxvl128-zvDI5_Bch-fNm62ioEOv2_hcfDh09vXz7DBGypoPJTBYNPU-Mx3hphEeIIjGUQLf7uJpodvPh4ckdSBgVjBdEc8DQG2gJIGI0MwhWGxZkEKcOJIegObkzLUFhZkrURuVelNYEVhdEGDp1qxW2i3aRt_B2FwdsMZFZYHx6VzNtiSCRm4CCoADM3QY5B0NRpA1ScnTFZJKVVUSjUoJUP7ozqq-cDJ8e_pr6LK1lMjoXb_ol18rpJ_VtaVOijvnRWQsJrSysKVTgnjmJNG0gztjQrfrBHApI4JKy8z9HA9DP4ZD11M49vVMEfAppjDnNuDfaxXwgSPbF4sQ-WW5WwtdXukOf3Sc4DrCL6Euvt_oriHLtNYvhG5Kos9tNstVv4-gKrOPugd5Reu-x_Z priority: 102 providerName: Scholars Portal |
Title | Non-pharmacological therapies for postviral syndromes, including Long COVID: a systematic review and meta-analysis protocol |
URI | https://bmjopen.bmj.com/content/12/4/e057885.full https://www.ncbi.nlm.nih.gov/pubmed/35410933 https://www.proquest.com/docview/2649289947 https://search.proquest.com/docview/2649587007 https://pubmed.ncbi.nlm.nih.gov/PMC9002258 https://doaj.org/article/bc79f8eecb5448a7b61c7c85ac3c6a62 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2ISEkhGB8BUZlJB54WNbGX7F528rGQKRMaJvKU2Q7NhS1SbW2T_zznPPRrgjxwIsjJRfFyv3Od5fc_YzQG8OklZ6z2BXKxywdqFiLwsWae8VJwcmgCI3C2UicX7FPYz7eQbzrhamL9q2ZHJXT2VE5-VHXVs5ntt_VifUvsqEKnofL_i7aBfd7K0Wvl1_GFeekZRhKqOib2c-wFRUAgkDqDBCVYb8aylmgUgp0gSCw5ZZq9v6_hZx_Vk7eckVnD9GDNobEx81cH6EdV-6ju1n7l3wf3W--xeGmxegx-jWqyni-4agOesFN4xXkyRjCVjyvFstQ7jvFHYXB4hBPSjtdBd-GP1cwDL9cf3z_Dmu8YX_GTecL1mWBZ26pY91ynODA_1DB056gq7PTy-F53G66EBtO1TJ2xHuw-pR4LbzXiaahTUFwsNvAcwPrkdTEJIYwKvnAyNRpT5NEq4R4R5SkT9FeWZXuOcJg35pRwg3zlglrjTcp5cIz7qWHyDNCb-HN563RLPI6H6Eib_WVB33ljb4idNipJ583NBz_Fj8JKlyLBg7t-kR18z1vkZQbmyovnbOGQ46qUyMSm1rJtaVWaEEidNABYDNHiB9VyFFZGqHX68tgkuE_iy5dtWpkOKyDA5B51uBlPZMOdRFKt5C0NdXtK2AFNe13i_oX_33nS3SPhOaNwFSZHKC95c3KvYKQaml6YEjjFEb17bKH7hwPs-wajieno4uvcKzx1as_V8D4YZzAmDHZqw3vN77MK5A |
link.rule.ids | 230,314,727,780,784,864,885,2102,2221,12056,21388,24318,27924,27925,31719,31720,33744,33745,38516,43310,43805,43895,53791,53793,55349,55350,73745,74302,74412,77660,77686,77707 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELXoVgIufBcCBYzEgUPTbuzYSbggKFRb2F0uLerNsh0bCm2ydLMX-PPMJM4uW6EeuOTgjBQ7bzyesT1vCHlp0tzmXqSxKwsfp9mwiLUsXayFLwQrBRuWmCg8mcrRcfrxRJyEDbd5uFbZ28TWUJe1xT3yPVi4CwwO0uzN7GeMVaPwdDWU0Nggm1jFWwzI5v7nL4fvl7ss4LAUQrBAN5RwuWfOv2NdKtAOBnE06CtWUd6A1rWFqeXv_5fTefnu5F-L0cFtovphdHdQfuwuGrNrf11iePz_cd4ht4KfSt92inWXXHPVPXJ9Ek7i75Pf07qKZyvea8SadslcEHtTcIXprJ43eIX4jPa0CPMdelrZswWul3Rcw6P9j6-ppitGadpl01BdlfTcNTrWgTeFIqdEDV97QI4PPhztj-JQyCE2ghdN7Jj3YEky5rX0XieaY-qDFGALkDsHbFyumUkMAxDF0OSZ054niS4S5h0rcr5FBlVduUeEgs3QKWfCpN6m0lrjTcaF9KnwuQdvNiKvAEsVJuJctTEOlyrArhB21cEekZ0ecDXrqD2uFn-HSrEURV7utqG--KrCNFfGZoXPnbNGQNyrMyMTm9lcaMut1JJFZLtHfdXHFeQRebF8DdMcz2505epFJyPAtg5B5mGngcuecJEiKRiPSLamm2tdXX9TnX5rqcQL9OFE_vjqbj0nN0ZHk7EaH04_PSE3GWaAIN1lsk0GzcXCPQW_rDHPwuT7A30nO60 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELboVqq4IN4NFDASBw6NduNXYi6IPlYttEuFKOotsh0bitpk6WZP_HlmEu8ui1AvOTgjxcq87ZlvCHljReGKIEXqKx1SkY90alTlUyODlqySbFRho_DpRB2di48X8iLWP81iWeXCJnaGumocnpEPwXFrTA5EPgyxLOLsYPx--ivFCVJ40xrHaWyQTfCKIzYgm3uHk7MvyxMXCF60lCxCD2VcDe31T5xRBZLCIKcG2cWJyhuwuuakOiz__wWg_9ZR_uWYxvfJvRhR0g-9CDwgd3z9kGydxjvzR-T3pKnT6QqhGrlC-7YryJIpBK102sxaLPa9ogsAg9kuvazd1Rw9Gz1p4LH_-dvxwTtq6Ar7mfZ9L9TUFb32rUlNRDihiP7QwNcek_Px4df9ozSOXEit5LpNPQsBdD5nwagQTGY4NikoCVqLKDdgjQrDbGaZ4IUc2SL3JvAsMzpjwTNd8CdkUDe13yYUtNsIzqQVwQnlnA0251IFIUMRIO5MyFv402VUmVnZZSNclZEpJTKl7JmSkN0FO8ppD8JxO_kesmxJigja3UJz872MCllal-tQeO-shAzV5FZlLneFNI47ZRRLyM6C4as9roQwIa-Xr0Eh8ZbF1L6Z9zQSrOAIaJ728rHcCZcC4bt4QvI1yVnb6vqb-vJHB_qtMdqSxbPbt_WKbIFWlCfHk0_PyV2GrRqIS5ntkEF7M_cvIIBq7cuoGX8AdTkc3Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Non-pharmacological+therapies+for+postviral+syndromes%2C+including+Long+COVID%3A+a+systematic+review+and+meta-analysis+protocol&rft.jtitle=BMJ+open&rft.au=Chandan%2C+Joht+Singh&rft.au=Brown%2C+Kirsty&rft.au=Simms-Williams%2C+Nikita&rft.au=Camaradou%2C+Jenny&rft.date=2022-04-11&rft.issn=2044-6055&rft.eissn=2044-6055&rft.volume=12&rft.issue=4&rft.spage=e057885&rft_id=info:doi/10.1136%2Fbmjopen-2021-057885&rft.externalDBID=n%2Fa&rft.externalDocID=10_1136_bmjopen_2021_057885 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-6055&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-6055&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-6055&client=summon |